Nancy Masten insider trades: Baker Hughes (BKR) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Nancy reports to the SEC
and 3 more companies
Open-market buys and sales
47 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 21, 2025 | BKR | ↓ Sell | 80,000 | $46.37 | $3.7M | By trust | Feb 25, 2025 (4d) |
| Nov 6, 2024 | BKR | ↓ Sell | 10,000 | $40.69 | $407K | By trust | Nov 7, 2024 (1d) |
| Oct 31, 2024 | BKR | ↓ Sell | 5,000 | $38.02 | $190K | By trust | Nov 4, 2024 (4d) |
| Oct 24, 2024 | BKR | ↓ Sell | 10,000 | $37.10 | $371K | By trust | Oct 28, 2024 (4d) |
| Jun 30, 2022 | NEM | ↓ Sell10b5-1 | 10,000 | $61.50 | $615K | By Timothy J. and Nancy K. Buese Revocab | Jul 1, 2022 (1d) |
| Mar 30, 2022 | NEM | ↓ Sell10b5-1 | 10,000 | $79.00 | $790K | By Timothy J. and Nancy K. Buese Revocab | Apr 1, 2022 (2d) |
| Dec 30, 2021 | NEM | ↓ Sell10b5-1 | 10,000 | $60.78 | $608K | By Timothy J. and Nancy K. Buese Revocab | Jan 3, 2022 (4d) |
| Sep 30, 2021 | NEM | ↓ Sell10b5-1 | 10,000 | $52.29 | $523K | By Timothy J. and Nancy K. Buese Revocab | Oct 1, 2021 (1d) |
| Jun 30, 2021 | NEM | ↓ Sell10b5-1 | 10,000 | $62.84 | $628K | By Timothy J. and Nancy K. Buese Revocab | Jul 2, 2021 (2d) |
| Mar 30, 2021 | NEM | ↓ Sell10b5-1 | 10,000 | $61.00 | $610K | By Timothy J. and Nancy K. Buese Revocab | Apr 1, 2021 (2d) |
| Dec 30, 2020 | NEM | ↓ Sell10b5-1 | 11,250 | $59.80 | $673K | By Timothy J. and Nancy K. Buese Revocab | Dec 31, 2020 (1d) |
| Sep 30, 2020 | NEM | ↓ Sell10b5-1 | 11,250 | $62.49 | $703K | By Timothy J. and Nancy K. Buese Revocab | Oct 2, 2020 (2d) |
| Jun 30, 2020 | NEM | ↓ Sell10b5-1 | 11,250 | $59.68 | $671K | By Timothy J. and Nancy K. Buese Revocab | Jul 2, 2020 (2d) |
| Mar 30, 2020 | NEM | ↓ Sell10b5-1 | 11,250 | $46.96 | $528K | By Timothy J. and Nancy K. Buese Revocab | Apr 1, 2020 (2d) |
| Nov 27, 2019 | NEM | ↓ Sell10b5-1 | 7,500 | $37.83 | $284K | By Timothy J. and Nancy K. Buese Revocab | Nov 29, 2019 (2d) |
| Aug 29, 2019 | NEM | ↓ Sell10b5-1 | 7,500 | $40.96 | $307K | By Timothy J. and Nancy K. Buese Revocab | Aug 29, 2019 (0d) |
| May 28, 2019 | NEM | ↓ Sell10b5-1 | 7,500 | $31.63 | $237K | By Timothy J. and Nancy K. Buese Revocab | May 30, 2019 (2d) |
| Dec 3, 2018 | NEM | ↓ Sell10b5-1 | 2,000 | $32.88 | $66K | By Timothy J. and Nancy K. Buese Revocab | Dec 6, 2018 (3d) |
| Nov 1, 2018 | NEM | ↓ Sell10b5-1 | 2,000 | $31.51 | $63K | By Timothy J. and Nancy K. Buese Revocab | Nov 2, 2018 (1d) |
| Oct 1, 2018 | NEM | ↓ Sell10b5-1 | 2,000 | $30.20 | $60K | By Timothy J. and Nancy K. Buese Revocab | Oct 3, 2018 (2d) |
| Sep 4, 2018 | NEM | ↓ Sell10b5-1 | 2,000 | $30.53 | $61K | By Timothy J. and Nancy K. Buese Revocab | Sep 6, 2018 (2d) |
| Aug 1, 2018 | NEM | ↓ Sell10b5-1 | 2,000 | $36.45 | $73K | By Timothy J. and Nancy K. Buese Revocab | Aug 3, 2018 (2d) |
| Jul 2, 2018 | NEM | ↓ Sell10b5-1 | 2,000 | $37.47 | $75K | By Timothy J. and Nancy K. Buese Revocab | Jul 3, 2018 (1d) |
| Jun 1, 2018 | NEM | ↓ Sell10b5-1 | 2,000 | $38.88 | $78K | By Timothy J. and Nancy K. Buese Revocab | Jun 5, 2018 (4d) |
| May 1, 2018 | NEM | ↓ Sell10b5-1 | 2,000 | $38.97 | $78K | By Timothy J. and Nancy K. Buese Revocab | May 3, 2018 (2d) |
| Sep 23, 2016 | MPLX | ↓ Sell | 15,000 | $32.81 | $492K | Direct | Sep 27, 2016 (4d) |
| May 23, 2016 | MPLX | ↓ Sell | 5,000 | $34.00 | $170K | Direct | May 24, 2016 (1d) |
| Mar 30, 2015 | MWE | ↓ Sell10b5-1 | 10,000 | $63.00 | $630K | Direct | Mar 31, 2015 (1d) |
| Jul 28, 2014 | MWE | ↓ Sell10b5-1 | 10,000 | $71.79 | $718K | Direct | Jul 28, 2014 (0d) |
| Sep 30, 2013 | MWE | ↓ Sell10b5-1 | 5,000 | $72.00 | $360K | Direct | Sep 30, 2013 (0d) |
| Sep 19, 2013 | MWE | ↓ Sell10b5-1 | 5,000 | $70.00 | $350K | Direct | Sep 23, 2013 (4d) |
| Sep 12, 2013 | MWE | ↓ Sell10b5-1 | 5,000 | $69.52 | $348K | Direct | Sep 13, 2013 (1d) |
| Apr 23, 2013 | MWE | ↓ Sell10b5-1 | 5,000 | $62.00 | $310K | Direct | Apr 23, 2013 (0d) |
| Apr 8, 2013 | MWE | ↓ Sell10b5-1 | 5,000 | $60.00 | $300K | Direct | Apr 10, 2013 (2d) |
| Dec 10, 2012 | MWE | ↓ Sell10b5-1 | 15,000 | $51.09 | $766K | Direct | Dec 10, 2012 (0d) |
| Feb 10, 2012 | UMBF | ↑ Buy | 250 | $40.01 | $10K | Direct | Feb 13, 2012 (3d) |
| Feb 6, 2012 | MWE | ↓ Sell10b5-1 | 10,000 | $58.33 | $583K | Direct | Feb 6, 2012 (0d) |
| Oct 28, 2011 | MWE | ↓ Sell10b5-1 | 2,900 | $50.00 | $145K | Direct | Oct 28, 2011 (0d) |
| Aug 9, 2011 | UMBF | ↑ Buy | 500 | $36.29 | $18K | Direct | Aug 10, 2011 (1d) |
| Jul 7, 2011 | MWE | ↓ Sell10b5-1 | 7,100 | $50.01 | $355K | Direct | Jul 11, 2011 (4d) |
| Mar 8, 2011 | MWE | ↓ Sell10b5-1 | 10,000 | $45.57 | $456K | Direct | Mar 9, 2011 (1d) |
| May 21, 2010 | UMBF | ↑ Buy | 250 | $39.59 | $10K | Direct | May 24, 2010 (3d) |
| May 17, 2010 | MWE | ↓ Sell10b5-1 | 12,000 | $30.03 | $360K | Direct | May 17, 2010 (0d) |
| Apr 1, 2010 | MWE | ↓ Sell10b5-1 | 5,000 | $30.69 | $153K | Direct | Apr 5, 2010 (4d) |
| Feb 1, 2010 | MWE | ↓ Sell10b5-1 | 5,000 | $29.35 | $147K | Direct | Feb 2, 2010 (1d) |
| Dec 1, 2009 | MWE | ↓ Sell10b5-1 | 5,000 | $25.71 | $129K | Direct | Dec 1, 2009 (0d) |
| Nov 16, 2009 | MWE | ↓ Sell10b5-1 | 5,000 | $23.98 | $120K | Direct | Nov 17, 2009 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BKR insiders
Open-market trades in the last 12 months
About Nancy Masten's insider trades
Nancy Masten is EVP & Chief Financial Officer at Baker Hughes (BKR). Since Nov 16, 2009, Nancy has reported 3 open-market purchases worth $38K and 44 sales worth $19.3M on SEC Form 4. There have been no open-market trades in the last 12 months.
38 sales (72% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (52 filings), shares withheld for taxes (28 filings), option exercises (5 filings), gifts (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BKR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.